Your search has returned a large number of results. Try searching for a more specific term or phrase.
Patients
PATIENT ADVOCACY
At Alnylam, we believe that patients are experts in their experience. They are at the center of everything we do and every decision we make.
We are grateful to work alongside advocacy groups around the world,…,
Patient Advocacy Around the World
Working in more than 20 countries with over 60 Patient Advocacy Groups (PAGs)
ADVOCACY GROUP LEGEND:
Acute Hepatic Porphyria
Hereditary ATTR Amyloidosis
Primary…
Patients
NO-CHARGE GENETIC TESTING AND COUNSELING PROGRAM
Alnylam Act®
Alnylam Act® is a sponsored, no-charge, third-party genetic testing and counseling program for people with a family history or suspected diagnosis of certain genetic…, Watch the Alnylam Act® Video Introduction
, What Is Genetic Testing?
Genetic testing can identify changes to DNA that may lead to a genetic condition. Results of a genetic test can confirm or rule out a suspected genetic disease or help determine someone’s chance of developing or passing…
Patients
PATIENT SERVICES
Here for You
At Alnylam, we believe in going further than providing treatment options. That’s why we’ve established comprehensive support programs for those affected by the diseases we focus on.
, Access To Investigational Medicines
Here at Alnylam, we all live by a shared philosophy when it comes to patient access: our therapies must get to those who will benefit from them. We consider this philosophy our compass, guiding how we will…
Patients
PRIMARY HYPEROXALURIA
Understanding Primary Hyperoxaluria Type 1
Primary hyperoxaluria (PH) constitutes a group of rare inherited disorders of the liver characterized by the overproduction of oxalate, an end-product of…, What Are The Symptoms Of PH1?
People with PH1 often experience the formation of oxalate stones throughout the urinary tract and kidneys.
When a person with PH1 has a kidney stone, symptoms can include:
Flank pain
Painful …, Ph1 Inside The Body
, Understanding PH1: One family’s story
Three of Jared and Natalie’s four children were born with PH1. Hear from Claire and Benson about what it’s like to live with this rare inherited disorder.
Patients
ACUTE HEPATIC PORPHYRIA
Understanding Acute Hepatic Porphyria
Acute hepatic porphyria (AHP) refers to a family of ultra-rare, genetic diseases characterized by potentially life-threatening attacks and, for some patients, chronic…,
Acute Hepatic Porphyria Symptoms Can Impact Quality of Life
Affected individuals can experience some combination of the following symptoms:
Severe, diffuse abdominal pain, vomiting/nausea, dark/reddish urine, hyponatremia
Muscle weakness…,
Acute Hepatic Porphyria Symptoms Can Impact Quality of Life
Affected individuals can experience some combination of the following symptoms:
Severe, diffuse abdominal pain, vomiting/nausea, dark/reddish urine, hyponatremia…,
What Causes Acute Hepatic Porphyria?
,
What causes acute hepatic porphyria?
In people with the genetic defect for AHP, one of the enzymes in the pathway that creates heme is deficient. Certain triggers can impact the pathway and can cause an…, What Is It Like to Live With and Care for a Person With Acute Hepatic Porphyria (AHP)?
Medical Professionals
EARLY ACCESS PROGRAM FOR LUMASIRAN
Lumasiran is a subcutaneously administered RNAi therapeutic targeting hydroxyacid oxidase 1 (HAO1)—the gene encoding glycolate oxidase (GO)—for the treatment of primary hyperoxaluria…
Medical Professionals
ACCESS TO INVESTIGATIONAL THERAPIES
Helping Eligible Patients Gain Access to Alnylam Investigational Therapies
Alnylam is dedicated to developing new therapies that have a positive impact on patient health, and to…, Early Access Programs Currently Open
Medical Professionals
GENETIC TESTING AND COUNSELING PROGRAM
Alnylam Act®
Alnylam Act® is a sponsored, no-charge, third party genetic testing and counseling program for patients with a family history or suspected diagnosis of hereditary…,
How Genetic Counseling Works
Genetic counseling is an optional service available to patients in the U.S. and Canada that provides information and support for patients who have, or may be at risk for, genetic conditions. Genetic counselors are…
Medical Professionals
INFORMATION FOR MEDICAL PROFESSIONALS
Alnylam is committed to supporting and partnering with the healthcare community across the disease areas in which we work. We actively engage with medical professionals through our…, Our robust pipeline of investigational RNAi therapeutics is currently focused on several disease areas including transthyretin amyloidosis, rare diseases, cardiovascular diseases, metabolic diseases, and neurological diseases.
, Alnylam Grant Information
Alnylam is committed to supporting the medical and scientific understanding of our therapeutic areas of interest for healthcare professionals. Additionally, we are committed to supporting educational programs and…
The page you are looking for is not found
The page you are looking for does not exist. It may have been moved, or removed altogether. Perhaps you can return back to the site’s homepage and see if you can find what you are looking for.…
You are now leaving Alnylam.com
The following content may not be associated with Alnylam Pharmaceuticals.
Links to all outside sites are provided as a reference for our visitors.
Alnylam Pharmaceuticals does not endorse and is not responsible for the content on sites that are not owned and operated by Alnylam Pharmaceuticals.
Proceed to SiteYou are now leaving Alnylam.com
You will be directed to another Alnylam website that may contain information about specific treatment(s), news and more.
Proceed to Site
You will be redirected to an external site that may include social media, event registration, or other third-party content related to Alnylam.
Please note that these external sites have their own terms of service and privacy policies, which may differ from those of Alnylam.
Proceed to Site